drugset
drugset / Press release

The European Commission (EC) has granted Orphan Drug Designation to L19TNF

2016-10-28 · Philogen S.p.A. · original philogen.com ↗

Onfekafusp alfa · regulatory

Philogen S.p.A. announced that the European Commission (EC) has granted Orphan Drug Designation to L19TNF for the treatment of soft-tissue sarcoma. PHILOGEN S.P.A. RECEIVES ORPHAN DRUG DESIGNATION FOR THE TREATMENT OF SOFT-TISSUE SARCOMA

The release as fetched from its publisher. philogen.com ↗